🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522652-58-01
Completed Phase I

A trial to test the safety and tolerability of Lu AH70212 and Lu AH69593 in healthy adults.

2025-522652-58-01 · tracked via the Priya Life Science EU tracker
Sponsor
H. Lundbeck A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nervous System Diseases
Decision date
09/02/2026
Enrollment target
104
Sites
France

Condition studied

Narcolepsy

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522652-58-01 on CTIS ↗ ← All trials in the EU